About IPEC-Americas

How IPEC-Americas Is Different:
Unlike PhRMA, GPhA, CHPA, and other U.S. industry associations whose primary focus is on the action of finished drugs and pharmacologically active ingredients and whose principal members are manufacturers and marketers of final pharmaceutical dosage forms, IPEC-Americas members also include firms that make bulk excipients that go into a finished drug product.

This unique partnership of makers and users of drug components works well in IPEC-Americas in part because of the relationship which frequently exists between international pharmaceutical marketers and their counterparts among multinational suppliers of excipients for global use. Often, the impetus to qualify an excipient for a new use in pharmaceuticals or in a new or different dosage form can lead to joint ventures between the producers and potential formulators for necessary testing & submission of data to U.S. and other national regulatory authorities. Cooperation, therefore, is based on the shared goal of both users and producers to qualify a single formulation for marketing in many countries.

• Mission Statement
• What is IPEC?
• What IPEC Does
• Membership Benefits
• Why IPEC is Needed
• What We're Doing Now
  
  For more information on IPEC...
  ...and to learn more about how your company can benefit by joining IPEC-Americas, you are invited to contact:
  
  info@ipecamericas.org
  

Mailing Address: